Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

Clinical trial NCT00803933 · COMPLETED

Trial details

NCT number: NCT00803933
Sponsor: Immtech Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

African Trypanosomiasis

Start date: 2003-02-01
Primary completion: 2004-02-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.